Skip to main content

Table 2 Proportion of the HCV risk practices at baseline and at M12 and impact of time on HCV risk practices: univariate mixed models

From: Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

  Baseline (MO) M12 OR [95% CI] p
n (%) n (%) M12 vs. M0
Sharing injection paraphernalia 1 (0.6%) 1 (0.7%) 1.22 [0.08-19.59] 0.89
Needle sharing 3 (1.7%) 1 (0.7%) 0.40 [0.04-3.89] 0.43
Straw-sharing 9 (5.1%) 5 (3.5%) 0.64 [0.19-2.19] 0.48
At least 1 HCV risk practice associated with drug use 11 (6.3%) 6 (4.1) 0.63 [0.21-1.90] 0.42
At least 1 HCV risk practice associated with other practices 26 (16%) 18 (12%) 0.65 [0.30-1.45] 0.29
At least 1 HCV risk practice 34 (19%) 22 (15%) 0.68 [0.33-1.41] 0.30